Shots:
The US FDA has cleared the FreeStyle Libre 3 system for diabetes in patients aged ≥4yrs. The system is expected to be available in 2022 & will be available at the same price as previous versions of the system
The system is the world’s smallest, thinnest glucose sensor with 7.9% overall MARD that manages the patients’ health minute-by-minute. It also features improved BlueTooth integration with a range of ~33 feet
The 14-day glucose sensor pairs with the FreeStyle Libre 3 iOS & Android mobile apps to allow users to view glucose levels in real-time, track glucose history & trends & set up optional alarms. The app allows integration with the FreeStyle digital ecosystem including LibreView & LibreLinkUp
Ref: Abbott | Image: Abbott
